3D Systems has expanded its partnership with BioSummer Dental in France by adding the NextDent 300 MultiJet 3D printer to BioSummer's portfolio, aiming to increase access to digital denture production across Europe. This move follows 3D Systems' EU Medical Device Regulation certification, enabling broader commercialization of its dental materials and technology. The collaboration supports dental labs in improving efficiency and productivity through advanced 3D printing workflows, helping meet growing demand for high-quality dentures. The partnership is a strategic step to grow 3D Systems' presence in the European dental market and accelerate adoption of digital denture solutions.
The news on 3D Systems expanding its European dental presence provides context for readers following health-sector stocks. For readers following health-sector stocks on Pluang as of Nov 02, 2026 19:21 WIB: out of 150 priced US health stocks, 82 rose and 47 fell. Among notable movers, HRTX rose 4.43% to USD 0.29 with a typical hold time of 38 days, contrasting with MMED which fell 2.95% to USD 17.74 and MRVI which gained 2.82% to USD 8.03, both held typically for around two weeks or less.
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
